Trial Profile
Prospective rAndomized, Single-blind, multicenTral Control Clinical Trial of Sirolimus-eluting coRonary Stent "Calypso" (Angioline) vs Everolimus-elutIng cOronary stenT "Xience Prime" (Abbott Vascular)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms PATRIOT
- 14 Dec 2017 Status changed from recruiting to completed.
- 06 Sep 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 22 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Jul 2017.